An outstanding clinic
The Foundation for the Study of Viral Hepatitis (FEHV) is a non-profit organization leader in the field of hepatology at international level, with the best specialists in liver diseases and molecular biology. In our clinic located in Madrid, we treat all kinds of liver diseases (autoimmune hepatitis, cholangitis, fatty liver, viral hepatitis, etc.).
Our services
At the FEHV Clinic we offer you the levels of quality and medical service that have made our team an international medical reference.
Genetics
Complete genetic service applied to preventive diagnosis
Medical consultations
Medical consultations with diagnosis and ambulatory and hospital treatment in various specialties: Hepatology, Digestive…
Biopsies
Liver biopsies and abdominal ultrasound
Specialties
Hepatology
Nephrology
Digestive
Internal Medicine
Medical team

Dr. Vicente Carreño
Hepatologist
Founder and president of the foundation for the study of viral hepatitis
Currently, he is considered one of the best hepatologists internationally. Dr. Carreño is a member of the European and American Societies for the Study of Liver Diseases. He trained as a doctor and received his doctorate in 1985 from the Faculty of Medicine of the Autonomous University of Madrid. He developed his international career in Research Centers in Oxford, Berlin and London.
Read more about Dr. Vicente CarreñoLed by Dr. Vicente Carreño, we have three medical specialists in internal medicine, hepatology, digestive and nephrology, as well as specialists in the latest advances in radiology and ultrasound. We actively collaborate with the Biomedical Research Foundation, for advanced study in liver diseases and new diagnostic techniques.
REQUEST INFORMATION WITHOUT COMMITMENT
Learn more about liver diseases
In this section you can learn about diseases that mainly affect the liver and the digestive system. You can learn from the best specialists the details, treatments and cure of liver diseases.
Real cases
What they say about us
Reasons to choose us
Experience
More than 25 years guarantee us as a reference center in Spain to deal with your case
Personalized
Comprehensive monitoring of each patient by our specialists
Continuous training
We care about being at the forefront in the investigation of liver diseases
Latest posts
Resistant primary biliary cholangitis: treatment with Elafibranor
Elafibranor is a newly approved treatment for patients with primary biliary cholangitis (PBC) who do not respond adequately to ursodeoxycholic acid. Clinical studies show improved liver function and establish it as a promising therapeutic option.
New treatment for hepatitis B with Bepirovirsen
A study published in The New England Journal of Medicine shows that Bepirovirsen significantly increases the likelihood of achieving a functional cure for chronic hepatitis B.
Interaction between fatty liver and Hepatitis B
Fatty liver and hepatitis B can coexist and worsen liver damage. Combined treatment helps reduce inflammation, fibrosis, and disease progression.